Division of Nephrology, West China Hospital of Sichuan University, Chengdu 610041, China.
The Faculty of Social Development and Western China Development Studies, Sichuan University, China.
Dis Markers. 2019 Sep 15;2019:4354061. doi: 10.1155/2019/4354061. eCollection 2019.
The performance of various equations for estimated glomerular filtration rate (eGFR) in patients with diabetes remains controversial. We aimed to evaluate the performance of equations for eGFR in Chinese patients with diabetic nephropathy (DN).
This is a retrospective study included in 308 patients with type 2 diabetes and biopsy-proven DN who were followed up at least one year. eGFR was calculated using chronic kidney disease epidemiology (CKD-EPI) equations based on serum creatinine (eGFR), cystatin C (eGFR), and joint equations (eGFR), respectively. End-stage kidney disease was defined by initiation of renal replacement therapy. The eGFR concordance between equations was assessed by Bland-Altman plots. Log-rank and multivariable logistic regression were employed to evaluate the performance of equations.
Overall, the proportion of patients with eGFR < 60 mL/min/1.73m was 53%, 70%, and 61% by the equations of eGFR, eGFR, and eGFR, respectively. Higher disconcordance was observed between equations when eGFR > 60 mL/min/1.73m. Compared with eGFR, 39% of patients were reclassified (reclassified group) from CKD 1-2 stages to CKD 3-5 stages by eGFR and they presented significantly longer diabetic duration, heavier proteinuria, advanced pathological lesions, and poorer kidney outcomes. Multivariable logistic regression indicated cystatin C was independently associated with advanced glomerular classifications.
eGFR equations incorporating cystatin C are superior to eGFR based on creatinine alone for detecting kidney injury in the early stage. The independent association between cystatin C and glomerular classifications might contribute to it.
各种估算肾小球滤过率(eGFR)方程在糖尿病患者中的表现仍存在争议。我们旨在评估这些方程在伴有糖尿病肾病(DN)的中国患者中的表现。
这是一项回顾性研究,纳入了至少随访 1 年的 308 例 2 型糖尿病和肾活检证实的 DN 患者。分别采用基于血清肌酐(eGFR)、胱抑素 C(eGFR)和联合方程(eGFR)的慢性肾脏病流行病学(CKD-EPI)方程计算 eGFR。终末期肾病的定义为开始肾脏替代治疗。通过 Bland-Altman 图评估方程之间的 eGFR 一致性。Log-rank 和多变量逻辑回归用于评估方程的性能。
总体而言,eGFR、eGFR 和 eGFR 方程分别有 53%、70%和 61%的患者 eGFR<60mL/min/1.73m。当 eGFR>60mL/min/1.73m 时,方程之间的不一致性更高。与 eGFR 相比,eGFR 将 39%的患者从 CKD 1-2 期重新分类(重新分类组)为 CKD 3-5 期,这些患者的糖尿病病程更长、蛋白尿更重、病理损伤更严重、肾脏结局更差。多变量逻辑回归表明胱抑素 C 与晚期肾小球分类独立相关。
与仅基于肌酐的 eGFR 方程相比,纳入胱抑素 C 的 eGFR 方程更能早期检测肾脏损伤。胱抑素 C 与肾小球分类之间的独立相关性可能与其相关。